bluebird bio, Inc.

Equity-NMS: BLUE

Healthcare | Biotechnology

$4.970 (March 29, 2026)

bluebird bio, Inc. Chart

bluebird bio, Inc. Performance

Days Range

Previous Close: $4.97
Open: $undefined
EPS(TTM):
Shares O/S: -
Day's Range$undefined - $undefined
52W Range$undefined - $undefined
Market Cap-

About bluebird bio, Inc.

bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. It markets three gene therapies: ZYNTEGLO (betibeglogene autotemcel, also known as beti-cel), SKYSONA (elivaldogene autotemcel, also known as eli-cel), and LYFGENIA (lovotibeglogene autotemcel, also known as lovo-cel). ZYNTEGLO is the first gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions. SKYSONA is used to slow the progression of neurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). LYFGENIA is used for the treatment of sickle cell disease in patients ages 12 and older who have a history of vaso-occlusive events (VOEs).

Frequently Asked Questions

bluebird bio, Inc. (BLUE) share price as of March 29, 2026 is $4.97. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the bluebird bio, Inc. (BLUE) Share by opening an international trading account with Angel One.
Purchasing bluebird bio, Inc. (BLUE) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying bluebird bio, Inc. (BLUE) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of bluebird bio, Inc. (BLUE) or any other US company shares in Angel One for any dollar amount.
The market capitalization of bluebird bio, Inc. on February 11, 2026, is $-.
bluebird bio, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry.
In order to invest in bluebird bio, Inc. (BLUE) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Open Free Demat Account!
Join our 3.5 Cr+ happy customers